首页> 外国专利> Lung cancer specific gene products: their coding sequence, their antibodies and their use in diagnostic, therapeutic and disease management of lung cancer

Lung cancer specific gene products: their coding sequence, their antibodies and their use in diagnostic, therapeutic and disease management of lung cancer

机译:肺癌特异性基因产物:其编码序列,抗体及其在肺癌的诊断,治疗和疾病管理中的用途

摘要

The present invention relates to the disclosure of a group of gene products, polypeptides and their derivatives, their corresponding polynucleotide sequences (DNA and RNA), and specific antibodies to said gene products and derivatives. It is shown that said gene products are differentially expressed in lung cancer patients versus normal controls, using either tissues or biological fluids as specimens. Also provided is a procedure for producing the cancer specific gene products by recombinant techniques. This invention also pertains to the use of said antibodies in characterizing the gene products of the present invention, and in diagnostic, and disease management applications. The present invention also pertains to the therapeutic use of said antibodies and gene products to treat cancer and other human diseases. The invention also relates to composition, kits, and methods for detecting, characterizing, preventing, and treating human lung cancer.
机译:本发明涉及一组基因产物,多肽及其衍生物,其相应的多核苷酸序列(DNA和RNA)以及针对所述基因产物和衍生物的特异性抗体的公开。结果表明,使用组织或生物液体作为样本,所述基因产物在肺癌患者中相对于正常对照差异表达。还提供了通过重组技术生产癌症特异性基因产物的方法。本发明还涉及所述抗体在表征本发明的基因产物以及在诊断和疾病管理应用中的用途。本发明还涉及所述抗体和基因产物在治疗癌症和其他人类疾病中的治疗用途。本发明还涉及用于检测,表征,预防和治疗人肺癌的组合物,试剂盒和方法。

著录项

  • 公开/公告号US2005048589A1

    专利类型

  • 公开/公告日2005-03-03

    原文格式PDF

  • 申请/专利权人 MONCEF JENDOUBI;

    申请/专利号US20040926543

  • 发明设计人 MONCEF JENDOUBI;

    申请日2004-08-25

  • 分类号G01N33/574;C07K16/30;

  • 国家 US

  • 入库时间 2022-08-21 22:21:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号